Find clinical trials for Triple Negative Breast Cancer in Los Angeles, CA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Triple Negative Breast Cancer trials near Los Angeles, CA, USA:
The purpose of this study is to test the safety and tolerability of PMD-026 in patients with metastatic breast cancer and triple...
Phase 1
Los Angeles, California, United States and 8 other locations
or paclitaxel (cohort 1) or with sacituzumab govitecan-hziy (cohort 2) in patients with non-surgically removable locally advanced or metastatic triple...
Phase 2
Santa Monica, California, United States and 44 other locations
of durvalumab in combination with novel oncology therapies with or without paclitaxel and durvalumab + paclitaxel for first-line metastatic triple...
Phase 1, Phase 2
West Hollywood, California, United States and 46 other locations
in patients with unresectable, locally advanced or metastatic triple-negative breast cancer (TNBC) who received a...
Phase 2
Los Angeles, California, United States and 21 other locations
to see how well they they work in shrinking tumors in patients with triple negative breast cancer that has spread...
Phase 1, Phase 2
Los Angeles, California, United States
This trial studies ladiratuzumab vedotin (LV) with pembrolizumab in patients with triple-negative breast cancer. -...
Phase 1, Phase 2
Los Angeles, California, United States and 49 other locations
selective inhibition of phosphoinositide-3-kinase (PI3K)-gamma, in combinations with Tecentriq and Abraxane (nab-paclitaxel) in front-line triple...
Phase 2
Santa Monica, California, United States and 23 other locations
This is a phase 1b/2 study to evaluate the safety and efficacy of metronomic combination therapy in subjects with TNBC who have progressed on or afte...
Phase 1, Phase 2
El Segundo, California, United States
doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC). Usually, after neoadjuvant therapy and surgery for triple ne ...
Phase 3
Los Angeles, California, United States and 216 other locations
This phase I trial tests the safety, side effects, and best dose of CF33-hNIS-antiPDL1 in treating patients with triple negative br ...
Phase 1
Duarte, California, United States
Clinical trials
Research sites
Resources
Legal